HIF1A and cervical cancer: To explore the efficacy of NACT, the expression of HIF-1α, VEGF-A, and Ki67 in pre-chemotherapy and post-chemotherapy cervical cancer tissues between the chemotherapy response (CR + PR) group and the nonresponse (SD + PD) group were examined by IHC.